Articles

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;San Bortolo Hospital, Vicenza, Italy
University Hospital, Basel, Switzerland
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Roche Molecular Systems, Inc., Pleasanton, CA, USA
Roche Molecular Systems, Inc., Pleasanton, CA, USA
Roche Molecular Systems, Inc., Pleasanton, CA, USA
San Bortolo Hospital, Vicenza, Italy
University of Louisville School of Medicine, Louisville, KY, USA
Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Weill Medical College of Cornell University, New York, NY, USA
The Methodist Hospital, Houston, TX, USA
Columbia University Medical Center and New York Presbyterian Hospital, New York, NY, USA
University of California San Diego School of Medicine, San Diego, CA, USA
University of North Carolina School of Medicine, Chapel Hill, NC, USA
Cleveland Clinic, Cleveland, OH, USA
University of Maryland School of Medicine, Baltimore, MD, USA
University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China
Zhejiang University School of Medicine, Second University Hospital, Hangzhou, China
Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
City of Hope National Medical Center, Los Angeles, CA, USA
University of California San Francisco School of Medicine, San Francisco, CA, USA
University of North Carolina School of Medicine, Chapel Hill, NC, USA
San Raffaele H. Scientific Institute, Milan, Italy
San Raffaele H. Scientific Institute, Milan, Italy
University of Wisconsin Hospital and Clinic, Madison, WI, USA
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Gundersen Lutheran Health System, La Crosse, WI, USA
University Hospital, Basel, Switzerland
Hospital Universitario Marques de Valdecilla, IFIMAV, Santander, Spain
Odense University Hospital, Odense, Denmark
Roche Molecular Systems, Inc., Pleasanton, CA, USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vol. 98 No. 2 (2013): February, 2013 https://doi.org/10.3324/haematol.2012.066209